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The purpose of this study is to review and describe various
factors and biomarkers which relate to the onset and
progression of Alzheimer’s disease and review the current
literature on those biomarkers.
Conclusion
The enhanced capacity to detect and characterize biomarkers relating
to Alzheimer’s disease provides more effective diagnostic and
therapeutic measures to either stop the advance of, or potentially cure
Alzheimer’s disease.
This study focuses on biomarkers and related factors associated
directly or indirectly with Alzheimer’s disease. Fluid biomarkers,
inflammatory biomarkers and various imaging technologies are
considered. Amyloid βeta protein and tau protein are the two
major factors linked either causally or diagnostically with
Alzheimer’s. Concentrations of these two proteins in blood and
cerebrospinal fluid are evaluated for correlations to Alzheimer’s
disease onset and progression and are being studied to
determine whether they act independently or interact in some
manner. Amyloid βeta detected in plasma shows little or no
correlation with Alzheimer’s progression, whereas, tau protein
detected in cerebrospinal fluid correlates with Alzheimer’s
disease. Current literature has been reviewed for the detection,
characterization and correlation of various biomarkers with
Alzheimer’s disease.
I hypothesize that researchers studying biomarkers of
Alzheimer’s disease will find correlations between cerebrospinal
fluid, amyloid βeta and tau proteins.
Methods
• A pool of 50-60 articles was taken from 6 journals (Neuro-
Image Clinic, Neurobiology of Aging, PLoS Medicine,
Journal of the Neurological Sciences, Journal of Cerebral
Blood flow and Metabolism, and NIH-PA) that report on
Alzheimer’s disease from 2009 to present.
• 23 of these articles address the hematologic factors
associated with Alzheimer’s disease and used for
statistical data analyses.
• Excel 2013 was used to compare each article’s use of
biomarkers and the year in which these articles were
published.
• JMP file computed the p-value in chi-square, using
categorical analysis that compares the likelihood of Aβ
proteins and tau proteins being considered along with
studies of Cerebrospinal Fluid (CSF).
Results
Hypothesis
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Abstract
Response CSF Aligned Responses Responses Sample 
Aβ 40 N  13  
Aβ 40 Y  10  
Aβ 42 N  13  
Aβ 42 Y  10  
Tau N  13  
Tau Y  10  
P-tua N  13  




Responses of Aβ and 
tau proteins in relation 
to CSF (p<0.01).
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